MEDP vs SOLV: fair value comparison
Medpace Holdings, Inc. and Solventum Corporation · Updated 2026-09-07
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, SOLV currently sits closer to the top of our discount ranking. MEDP carries the stronger quality grade.
| MEDP | SOLV | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $573.29 | $91.69 |
| 12-month range | $417.54–$594.02 | $64.35–$90.95 |
| Sector rank | #89 of 113 Healthcare | #87 of 113 Healthcare |
| Quality grade | C | F |
| Leverage | Low | High |
| Margin trend | — | Contracting |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: MEDP fair value analysis · SOLV fair value analysis